These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 35693832)

  • 1. Patients With Inflammatory Bowel Disease Show IgG Immune Responses Towards Specific Intestinal Bacterial Genera.
    Bourgonje AR; Roo-Brand G; Lisotto P; Sadaghian Sadabad M; Reitsema RD; de Goffau MC; Faber KN; Dijkstra G; Harmsen HJM
    Front Immunol; 2022; 13():842911. PubMed ID: 35693832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic immunoglobulin responses to gut bacteria during inflammatory bowel disease.
    Rengarajan S; Vivio EE; Parkes M; Peterson DA; Roberson EDO; Newberry RD; Ciorba MA; Hsieh CS
    Gut Microbes; 2020 May; 11(3):405-420. PubMed ID: 31203722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The oral-gut axis: Salivary and fecal microbiome dysbiosis in patients with inflammatory bowel disease.
    Abdelbary MMH; Hatting M; Bott A; Dahlhausen A; Keller D; Trautwein C; Conrads G
    Front Cell Infect Microbiol; 2022; 12():1010853. PubMed ID: 36275026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral immune responses against gut bacteria in dogs with inflammatory bowel disease.
    Soontararak S; Chow L; Johnson V; Coy J; Webb C; Wennogle S; Dow S
    PLoS One; 2019; 14(8):e0220522. PubMed ID: 31369623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal and mucosal microbiota profiling in pediatric inflammatory bowel diseases.
    Putignani L; Oliva S; Isoldi S; Del Chierico F; Carissimi C; Laudadio I; Cucchiara S; Stronati L
    Eur J Gastroenterol Hepatol; 2021 Nov; 33(11):1376-1386. PubMed ID: 33470709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease.
    Nishino K; Nishida A; Inoue R; Kawada Y; Ohno M; Sakai S; Inatomi O; Bamba S; Sugimoto M; Kawahara M; Naito Y; Andoh A
    J Gastroenterol; 2018 Jan; 53(1):95-106. PubMed ID: 28852861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria.
    Macpherson A; Khoo UY; Forgacs I; Philpott-Howard J; Bjarnason I
    Gut; 1996 Mar; 38(3):365-75. PubMed ID: 8675088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiome and its relevance to indigenous inflammatory bowel diseases in China.
    Han A; Yang M; Chen B; Cao G; Xu J; Meng T; Liu Y; Wang Z; Zhou Y; Xu N; Han W; Sun H; Mei Q; Zhu L; Xiong M
    Gene; 2024 May; 909():148257. PubMed ID: 38367851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Composition of the gut microbiota in patients with inflammatory bowel disease in Saudi Arabia: A pilot study.
    Al-Amrah H; Saadah OI; Mosli M; Annese V; Al-Hindi R; Edris S; Alshehri D; Alatawi H; Alatawy M; Bahieldin A
    Saudi J Gastroenterol; 2023; 29(2):102-110. PubMed ID: 36695274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct patterns of IgG and IgA against food and microbial antigens in serum and feces of patients with inflammatory bowel diseases.
    Frehn L; Jansen A; Bennek E; Mandic AD; Temizel I; Tischendorf S; Verdier J; Tacke F; Streetz K; Trautwein C; Sellge G
    PLoS One; 2014; 9(9):e106750. PubMed ID: 25215528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease.
    Takahashi K; Nishida A; Fujimoto T; Fujii M; Shioya M; Imaeda H; Inatomi O; Bamba S; Sugimoto M; Andoh A
    Digestion; 2016; 93(1):59-65. PubMed ID: 26789999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysbiosis in the Gut Microbiota in Patients with Inflammatory Bowel Disease during Remission.
    Pisani A; Rausch P; Bang C; Ellul S; Tabone T; Marantidis Cordina C; Zahra G; Franke A; Ellul P
    Microbiol Spectr; 2022 Jun; 10(3):e0061622. PubMed ID: 35532243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Microbiota Flagellins Drive Adaptive Immune Responses in Crohn's Disease.
    Alexander KL; Zhao Q; Reif M; Rosenberg AF; Mannon PJ; Duck LW; Elson CO
    Gastroenterology; 2021 Aug; 161(2):522-535.e6. PubMed ID: 33844987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota signatures in inflammatory bowel disease.
    Vestergaard MV; Allin KH; Eriksen C; Zakerska-Banaszak O; Arasaradnam RP; Alam MT; Kristiansen K; Brix S; Jess T
    United European Gastroenterol J; 2024 Feb; 12(1):22-33. PubMed ID: 38041519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbial Disruptions in Inflammatory Bowel Disease: A Comparative Analysis.
    Ma J; Wang K; Wang J; Zeng Q; Liu K; Zheng S; Chen Y; Yao J
    Int J Gen Med; 2024; 17():1355-1367. PubMed ID: 38601196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabarcoding of colonic cleansing fluid reveals unique bacterial members of mucosal microbiota associated with Inflammatory Bowel Disease.
    Banzragch M; Sanli K; Stensvold CR; Kurt O; Ari S
    Scand J Gastroenterol; 2023; 58(11):1253-1263. PubMed ID: 37337895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin coating of faecal bacteria in inflammatory bowel disease.
    van der Waaij LA; Kroese FG; Visser A; Nelis GF; Westerveld BD; Jansen PL; Hunter JO
    Eur J Gastroenterol Hepatol; 2004 Jul; 16(7):669-74. PubMed ID: 15201580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal microbiota is associated with extraintestinal manifestations in inflammatory bowel disease.
    Hertz S; Anderson JM; Nielsen HL; Schachtschneider C; McCauley KE; Özçam M; Larsen L; Lynch SV; Nielsen H
    Ann Med; 2024 Dec; 56(1):2338244. PubMed ID: 38648495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.